Literature DB >> 15530479

Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.

William Nowatzke1, Mark J Sarno, Nathan C Birch, Douglas F Stickle, Tanya Eden, Thomas G Cole.   

Abstract

BACKGROUND: 1,5-Anhydroglucitol (1,5-AG) is a glucose analogue, which is decreased in hyperglycemic individuals. We report the technical performance of an assay (GlycoMark) on a chemistry analyzer, evaluation of analyte stability and determination of reference intervals for 1,5-AG in a non-diabetic US population.
METHODS: NCCLS protocols were followed to evaluate the reagent on a Hitachi 917 chemistry analyzer.
RESULTS: Intra- and interassay imprecision ranged from 1.3% to 3.8% and 0.79% to 3.7%, respectively. The assay was linear to 110 microg/ml. Interference from triglyceride, hemoglobin and bilirubin was <10% to concentrations of 12.6 mmol/l, 12.1 and 911.4 micromol/l, respectively. Correlation coefficients between lot numbers on the Hitachi 917 and between analyses on the Hitachi 917 and the Hitachi 7170 analyzers were >0.99. The lowest limit of detection was 0.49 microg/ml (mean+/-2 S.D.). 1,5-AG was stable at 4 degrees C for 7 days, at 22 degrees C for 5 days, at -80 degrees C for 14 days and for three freeze-thaw cycles at -80 degrees C. The US reference intervals (nonparametric 2.5th-97.5th percentiles) were 10.2-33.8 microg/ml (males) and 5.9-31.8 microg/ml (females).
CONCLUSIONS: The performance of the GlycoMark assay for the measurement of 1,5-AG was acceptable on the Hitachi 917 analyzer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530479     DOI: 10.1016/j.cccn.2004.08.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  19 in total

1.  Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.

Authors:  Sanjeev N Mehta; Natalie Schwartz; Jamie R Wood; Britta M Svoren; Lori Mb Laffel
Journal:  Pediatr Diabetes       Date:  2011-11-08       Impact factor: 4.866

2.  The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.

Authors:  Qiang Zhou; De-Bao Shi; Li-Ying Lv
Journal:  J Clin Lab Anal       Date:  2016-11-17       Impact factor: 2.352

3.  Epidemiology of Dysglycemia in Pregnant Oklahoma American Indian Women.

Authors:  Madona Azar; Julie A Stoner; Hanh Dung Dao; Lancer Stephens; Jean R Goodman; John Maynard; Timothy J Lyons
Journal:  J Clin Endocrinol Metab       Date:  2015-06-19       Impact factor: 5.958

4.  Detection of 1,5-Anhydroglucitol by Electrochemical Impedance Spectroscopy.

Authors:  Teagan L Adamson; Curtiss B Cook; Jeffrey T LaBelle
Journal:  J Diabetes Sci Technol       Date:  2014-02-21

Review 5.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

6.  A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.

Authors:  Y Wang; Y L Zhang; Y P Wang; C H Lei; Z L Sun
Journal:  Diabetes Metab Res Rev       Date:  2012-05       Impact factor: 4.876

Review 7.  Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.

Authors:  Aine M McKillop; Peter R Flatt
Journal:  Diabetes Care       Date:  2011-12       Impact factor: 19.112

8.  Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.

Authors:  Naoko Mukai; Toshiharu Ninomiya; Jun Hata; Yoichiro Hirakawa; Fumie Ikeda; Masayo Fukuhara; Taeko Hotta; Masafumi Koga; Udai Nakamura; Dongchon Kang; Takanari Kitazono; Yutaka Kiyohara
Journal:  Cardiovasc Diabetol       Date:  2015-06-24       Impact factor: 9.951

9.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

10.  Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.

Authors:  Jan Skupien; Sylwia Gorczynska-Kosiorz; Tomasz Klupa; Krzysztof Wanic; Eric A Button; Jacek Sieradzki; Maciej T Malecki
Journal:  Diabetes Care       Date:  2008-05-20       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.